A Illinois overview of physician-supervised GLP-1 treatment through Astra, including local access context and the cities we cover. Every statistic on this page links to its source.
36.0% of Illinois adults are living with obesity, and another 35.0% are classified as overweight — together, 71% of the state's adult population is above a healthy weight range (2023 BRFSS, CDC) 4.
Illinois also reports a notably sedentary adult population: 21.4% get no leisure-time physical activity at all in a typical month (2023 BRFSS, CDC) 4. Statewide population is 12,710,158 5.
No. A full-text verification of the complete Illinois HFS Medicaid fee-for-service Preferred Drug List, effective 07/27/2026 (150 pages), found no Wegovy, Zepbound, or Saxenda listing and no anti-obesity drug class anywhere in the document 1.
The state's formal prior-authorization criteria portal carries a published "GLP-1 RA and GIP Receptor Agonist" entry for the FFS program, effective 04/29/2025 23. The underlying criteria document is hosted as a Box-hosted .docx and was blocked to automated retrieval, so its exact diagnosis, BMI, and step-therapy language is not quoted here — the non-coverage finding rests on the verified PDL search, not on that document.
Two further caveats, stated rather than smoothed over: roughly 80% of Illinois Medicaid enrollees sit in HealthChoice Illinois MCOs, whose individual formularies were not checked against this FFS reference; and this page publishes no Illinois uninsured rate, because the only figure produced was an unverified manual summation across ACS Table B27001 cells rather than a clean pre-tabulated rate.
Astra's pricing is the same in every state we serve: compounded semaglutide from $68 per month and compounded tirzepatide from $118 per month on 12-month plans, or $145 and $250 per month when billed monthly. There is no local price list, no regional surcharge, and no state-specific discount.
Illinois median household income was $83,211 (2024 ACS 1-year estimate) 6. The price is the same in Chicago, in Peoria, and in every other state Astra serves.
Illinois has strong specialty-care density around Chicago, but large stretches of the state — downstate cities, rural counties, and smaller metros like Peoria — sit far from the nearest endocrinologist or obesity-medicine specialist, often meaning weeks of wait time for an in-person GLP-1 prescribing visit. Telehealth closes that distance: a licensed prescriber, lab-order coordination, and ongoing dose management become available to a patient anywhere in Illinois without the drive.
Physician licensing and telehealth-prescribing standards for Illinois are set by the Illinois Department of Financial and Professional Regulation (IDFPR) 7.
TODO — UNVERIFIED: this research pass did not confirm Illinois-specific telehealth rules for GLP-1 or weight-management prescribing (any Illinois Medical Practice Act telehealth provisions, required initial-visit modality, or controlled-substance telehealth carve-outs). No specific Illinois telehealth rule is stated as fact on this page until it is confirmed against IDFPR's own published regulations.
Astra treats patients in all 50 states, including Illinois.
Astra treats patients in Illinois through state-licensed physicians.
Astra's Illinois coverage starts with a dedicated look at Peoria — see local clinic pricing, population, and access detail specific to that market on the Peoria, Illinois page.
No. Illinois Medicaid Fee-For-Service covers GLP-1/GIP medications only for type 2 diabetes. The HFS Preferred Drug List (effective July 27, 2026) places every GLP-1/GIP drug — including Ozempic, Mounjaro, and Trulicity — under its diabetes drug class, and a full-text search of the 150-page formulary finds no listing for Wegovy, Zepbound, or Saxenda, and no anti-obesity drug class at all.
No. Astra charges the same nationwide, 12-month-plan price everywhere it operates, including Illinois: $68/month for semaglutide and $118/month for tirzepatide ($816 and $1,416 billed annually). Illinois residents pay the identical price as patients in any other state — there is no city or state markup, and no state-specific discount.
36.0% of Illinois adults are living with obesity, and another 35.0% are overweight, according to the CDC's 2023 BRFSS survey — meaning 71% of the state's adult population is above a healthy weight range.
Yes. Astra is licensed to treat patients in all 50 states, including every part of Illinois — from Chicago and its suburbs to downstate cities like Peoria and rural counties without a nearby obesity-medicine specialist.
Yes — see the Peoria, Illinois page for local clinic pricing, population, and access data specific to that market.
Last reviewed:
Educational information, not medical advice. Treatment requires evaluation by a licensed physician.